... for≥ 2 months. For group one (eventful) that included patients who developed vascular access thrombosis or stenosis over the study period, we collected Vasc-Alert risk score 2 months prior to the event and, for group two (uneventful), over 5 consecutive months. Vasc-Alert technology utilises routinely...

...P. Stratta; C. Canavese; S. Ferrero; A. Grill; G. Piccoli Lupus anticoagulant (LA), anticardiolipin (aCL), and/or antiphospholipid (aPL) antibodies are the hallmarks of the antiphospholipid syndrome, characterized by widespread thrombosis. The syndrome has been described as primary or secondary...

... Analysis of 120 cases of femoral vein catheterization for ≥2 days for hemodialysis in 89 hospitalized patients was performed to determine the frequency of catheter-related complications including infection and venous thrombosis. The rate of clinically significant complications was < 3.5...

... Sympathetic nervous system Denervation Thrombosis Nephrosclerosis Abstract Nitric oxide (NO) inhibits platelet adhesion and aggregation in vitro. In vivo, chronic inhibi­ tion of NO synthesis induces nephrosclerosis and hypertension. Although the pathophysio­ logical mechanism of this glomerular injury has...

...Vijay P. Khatri; Jay B. Fisher; Marc A. Granson Hypercoagulability is a recognized complication of the nephrotic syndrome which commonly affects the venous system. Arterial thrombosis is very rare. Multiple factors contribute to the predisposition to thromboembolism in this condition. This report...

...Sae Yong Hong; Dong Ho Yang Recently there has been a renewed interest in the possibility that lipoprotein(a) -Lp(a) – may be important in the pathogenesis of thrombosis-related disease. In nephrotic syndrome, hyperlipidemia is a common finding, and thrombosis is a major complication...

... study, 10 adult nephrotic patients with biological markers of thrombosis risk (severe hypoalbuminemia and/or anomalies of the fibrinolytic pathway and/or deficiency in coagulation inhibitors) were given 40 mg (4,000 U) of Enoxaparin daily for at least 3 months; 3 patients were treated for 3 months, 1...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Low molecular weight heparin Heparin Hemodialysis Thrombosis Antithrombin III-protease complexes D dimer Original...

... by thrombotic microangiopathy with widespread thrombi in small arteries and glomeruli. The possible relationship between lupus anticoagulant and the development of thrombosis at the small renal vessels level with the triggering of the scleroderma crisis is discussed. 1 03 1991 11 12 2008 © 1991...

..., instructions or products referred to in the content or advertisements. Heparin cofactor II Antithrombin III Proteinuria Nephrotic syndrome Thrombosis 30 04 1991 11 12 2008 Original Paper Nephron 1992:60:176-180 P. Toulon* S. Gandrille3 P. Remyb G. Chadeuf* M. H. Jouvin0 M. Aiacha...

... of twelve devices have been replaced because of thrombosis and two because of infection. Four patients have had 10 episodes of reduced blood flow. Streptokinase infusion into the DiaTAP button led to improved blood flow in 8 of 10 episodes. The 6-month survival rate of the DiaTAP access device was 67...

...Momir Polenakovic; Charles E. Ganote; Elizabeth V. Potter; Robert B. Jennings To study the relationship of renal vein thrombosis to membranous glomerulonephritis with the nephrotic syndrome, we attempted to simulate the former by occluding to 0.5 mm one renal vein in rats. Although increased...

... levels of antithrombin III and plasminogen are commonly cited as reasons. Less attention has been paid to changes in the hemostatic system which might protect against thrombosis. We found a high frequency of reduced α 2 -antiplasmin levels in 40 patients with nephrotic syndrome, correlating with serum...

..., Northwestern University Medical School, V. A. Lakeside Hospital, Chicago, 111.; Wayne State University School of Medicine, Detroit. Mich., and Departments of Pathology and Surgery, Rush-Presbyterian-St. Lukes' Medical Center, Chicago, III. Key Words. Renal allograft Thrombosis Fibrinolysis Rejection...